2017
DOI: 10.1007/s00404-017-4497-3
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmune progesterone dermatitis

Abstract: Autoimmune progesterone dermatitis (APD) is an exceptional condition affecting young women of childbearing age with a high prevalence during the third decade of life. The diagnosis should be confirmed using an intradermal skin test to progesterone, during the follicular phase of the menstrual cycle. APD represents an early manifestation of autoimmune disease. A case of APD is presented who after curative treatment did not develop other autoimmune diseases during a 6-year follow-up. Dermatologists, gynecologist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
17
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(17 citation statements)
references
References 0 publications
0
17
0
Order By: Relevance
“…It is proposed that the immune complex of immunoglobulin G and progesterone lead to erythema multiforme-type skin lesions and the intermittent eruption of the disease during the menstrual period. 6 Various therapies had been reported to treat APD, such as conjugated estrogens, oral contraceptives, corticosteroids, antihistamines, progesterone, tamoxifen, antiestrogen, danazol, gonadotropin-releasing hormone (GnRH) analogs and oophorectomy. 5 There are three pathogenetic hypotheses: (i) exogenous progesterone induced progesterone hypersensitivity by stimulating T-helper cells; (ii) higher level of endogenous progesterone during pregnancy may be another triggering factor; and (iii) alike hormones, such as glucocorticoids and mineralocorticoids, may cross-react.…”
Section: Case Reportmentioning
confidence: 99%
See 3 more Smart Citations
“…It is proposed that the immune complex of immunoglobulin G and progesterone lead to erythema multiforme-type skin lesions and the intermittent eruption of the disease during the menstrual period. 6 Various therapies had been reported to treat APD, such as conjugated estrogens, oral contraceptives, corticosteroids, antihistamines, progesterone, tamoxifen, antiestrogen, danazol, gonadotropin-releasing hormone (GnRH) analogs and oophorectomy. 5 There are three pathogenetic hypotheses: (i) exogenous progesterone induced progesterone hypersensitivity by stimulating T-helper cells; (ii) higher level of endogenous progesterone during pregnancy may be another triggering factor; and (iii) alike hormones, such as glucocorticoids and mineralocorticoids, may cross-react.…”
Section: Case Reportmentioning
confidence: 99%
“…4 Recurrent anaphylaxis resulting from ovarian hormone-related exacerbation in some patients indicates that it may be caused by gonadotropins or progesterone. 3,6 Antihistamines and corticosteroids can be used for symptomatic relief. 6 Various therapies had been reported to treat APD, such as conjugated estrogens, oral contraceptives, corticosteroids, antihistamines, progesterone, tamoxifen, antiestrogen, danazol, gonadotropin-releasing hormone (GnRH) analogs and oophorectomy.…”
Section: Case Reportmentioning
confidence: 99%
See 2 more Smart Citations
“…APD is an uncommon, poorly recognized, and under-diagnosed catamenial dermatoses associated with hypersensitivity reactions to progestagens (Detrixhe, Nikkels, & Dezfoulian, 2017). Skin lesions (urticaria, eczema or erythema multiforme-like) occur during the luteal phase of the menstrual cycle.…”
mentioning
confidence: 99%